Effect of IMB Model-Based Education for Women With Menopausal Hot Flashes (IMB)

February 6, 2026 updated by: Yeliz ILDIR ALTUN, Marmara University

The Effect of the Education Provided Based on the Information-Motivation-Behavioral Skills Model in Women Experiencing Hot Flashes During Menopause

This study was conducted to examine the effect of an education program based on the Information-Motivation-Behavioral Skills (IMB) Model on the level of hot flashes, overall menopausal symptoms, and quality of life in women experiencing hot flashes during the menopausal period.

The study consisted of an intervention group and a control group. The intervention group received a structured education program based on the IMB Model, while no education, counseling, or care intervention was provided to the control group. Both groups were assessed at baseline, and at the 1st and 3rd months following the intervention.

It is expected that the findings obtained from this study will demonstrate the effectiveness of IMB Model-based education in the management of menopausal vasomotor symptoms and contribute to the development of evidence-based nursing practices for women during the menopausal period.

Study Overview

Status

Active, not recruiting

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sivas
      • Sivas, Sivas, Turkey (Türkiye), 58000
        • Cumhuriyet University Health Services Application and Research Hospital, Obstetrics and Gynecology Outpatient Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:Women aged between 44 and 60 years.

Women in the perimenopausal or postmenopausal period.

A score of ≥ 10 on the Menopause-Specific Hot Flash Scale.

No diagnosis of severe chronic disease and no regular medication use related to such conditions.

Not receiving Hormone Replacement Therapy (HRT).

No diagnosed mental disorder requiring medical treatment.

Able to read, write, speak, and understand Turkish, with no language barriers.

Willingness to participate in the study and provision of voluntary informed consent.

-

Exclusion Criteria:Not meeting the inclusion criteria.

Initiation of Hormone Replacement Therapy during the study period.

Refusal to participate in the study.

Occurrence of an unexpected acute illness during the study period.

Withdrawal from the study at any stage by personal choice.

Incomplete completion of study questionnaires or forms after enrollment.

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: IMB Model-Based Education Group
A structured education program based on the Information-Motivation-Behavioral Skills (IMB) model was provided to women experiencing hot flashes during the menopausal period. The education program included information on the physiology of hot flashes, symptom management, lifestyle modifications, coping strategies, and the development of behavioral skills to manage menopausal symptoms.
A structured education program based on the Information-Motivation-Behavioral Skills (IMB) model was delivered to women experiencing hot flashes during menopause. The intervention aimed to enhance participants' knowledge, motivation, and behavioral skills related to the management of menopausal hot flashes. The educational content included information on the physiology of hot flashes, lifestyle modifications, symptom management strategies, coping techniques, and skills to support healthy behaviors. The program was delivered through planned educational sessions.
No Intervention: Control Group (No Education)
This group consisted of women experiencing hot flashes during the menopausal period who did not receive any education or intervention during the study period. Participants continued their usual daily routines.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hot Flash-Related Daily Interference
Time Frame: Baseline (pre-intervention), 1 month, and 3 months
Hot flash-related daily interference was assessed using the Hot Flash Related Daily Interference Scale, which evaluates the extent to which hot flashes interfere with daily activities and quality of life.
Baseline (pre-intervention), 1 month, and 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hot Flush Beliefs
Time Frame: Baseline (pre-intervention), 1 month, and 3 months
Hot flush-related beliefs were assessed using the Hot Flush Beliefs Scale (HFBS), which evaluates women's cognitive beliefs and perceptions related to hot flashes.
Baseline (pre-intervention), 1 month, and 3 months
Menopause-Specific Quality of Life
Time Frame: Baseline (pre-intervention), 1 month, and 3 months
Menopause-specific quality of life was assessed using the Menopause-Specific Quality of Life Scale, which evaluates the impact of menopausal symptoms on women's physical, psychological, and social well-being.
Baseline (pre-intervention), 1 month, and 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hatice YILDIZ, Prof.Dr., Marmara University, Faculty of Health Sciences, Department of Obstetrics and Gynecology Nursing, Basıbuyuk RTE Health and Education Campus, 34854-Maltepe- Istanbul, Türkiye

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 7, 2024

Primary Completion (Actual)

November 1, 2024

Study Completion (Estimated)

August 30, 2026

Study Registration Dates

First Submitted

February 6, 2026

First Submitted That Met QC Criteria

February 6, 2026

First Posted (Actual)

February 12, 2026

Study Record Updates

Last Update Posted (Actual)

February 12, 2026

Last Update Submitted That Met QC Criteria

February 6, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Menopausal Hot Flashes

Clinical Trials on IMB Model-Based Education Program

Subscribe